Adaptimmune Therapeutics PLC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Abingdon, Oxfordshire
SEC filing record 1 source field available
Fiscal year end
31 December
Adaptimmune Therapeutics PLC has filed 808 SEC EDGAR filings since 02 Oct 2014

SEC filing history

Showing 301-325 of 808 matching filings.

Per page
25
Current page
13
4

OWNERSHIP DOCUMENT

Filing date
02 Aug 2021
Reporting date
02 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Jul 2021
Reporting date
02 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Jul 2021
Reporting date
02 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Jul 2021
Reporting date
01 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
28 Jun 2021
Reporting date
28 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Jun 2021
Reporting date
01 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37368

DEF 14A

Filing date
08 Apr 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37368

PRE 14A

Filing date
29 Mar 2021
Reporting date
14 May 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
03 Mar 2021
Reporting date
03 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88833

SCHEDULE 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88833

SEC SCHEDULE 13G

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88833

ADAPTIMMUNE THERAPEUTICS PLC

Filing date
16 Feb 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .